Association between routinely reported symptoms and 3 month hospital admission and mortality risk: a landmark analysis investigation in 86,000 individuals with heart failure in the UK

Mohammad R Ali,Carolyn SP Lam,Anna Stromberg,Simon PP Hand,Sara Booth,Francesco Zaccardi,Gerry P McCann,Kamlesh Khunti,Claire A Lawson

DOI: https://doi.org/10.1101/2024.06.12.24308679

2024-06-12

Abstract:Objectives: In patients with heart failure (HF), investigate the association between symptoms recorded in routine primary care consultations and short-term (3-month) hospitalisation and mortality. Design: Landmark analysis using Royston-Parmar flexible parametric survival models fitted at three different timepoints (landmarks): baseline (diagnosis date), and 6 and 12 month post-diagnosis. Setting: Primary care database analysis using Clinical Practice Research Datalink (CPRD), linked to hospitalisations and mortality (1998 to 2020). Participants: Adults (>40 years) with a first code for HF diagnosis in primary or secondary care records. Exposures: Shortness of breath (SOB), ankle swelling, oedema, fatigue, chest pain, depression and anxiety measured in a 3-month time-window prior to HF diagnosis and in survivors at 6 and 12-months. Main outcome measures: 3-month first all-cause hospitalisation and mortality, separately. Secondary outcomes were hospitalisations for HF and non-cardiovascular disease. Results: There were 86,882 patients with a diagnosis of HF, of whom 62,742 and 54,555 survived 6 and 12 months, respectively. There were differential symptom associations among different landmarks and outcomes. The highest risk associations for symptoms recorded just prior to diagnosis (baseline) were for depression for all-cause hospitalisation (adjusted hazard ratio: 1.26; 95% CI 1.15, 1.39), for non-cardiovascular hospitalisation (1.15; 1.10, 1.21) and death (1.22; 1.09, 1.36) and SOB for HF hospitalisation (1.18; 1.12, 1.26). Patients with HF exhibiting symptoms just prior to 6 and 12 month landmarks had increased risk of hospitalisation and mortality: at 6-months, the highest risk associations were with symptoms of depression for all-cause hospitalisation (1.46; 1.25, 1.70) and non-CVD hospitalisation (1.46; 1.23, 1.74), SOB for HF-specific hospitalisation (1.72; 1.50, 1.98); ankle swelling for mortality (1.49; 1.14, 1.94). At the 12-month landmark, classic HF symptoms had the highest risk associations: ankle swelling for all-cause hospitalisation (1.47; 1.21, 1.79) and non-CVD hospitalisation (1.55; 1.24, 1.93); SOB for HF hospitalisation (1.99; 1.68, 2.35); and fatigue for mortality (1.57; 1.22, 2.03). Conclusions: Symptoms reported by patients with HF were more prominent in patients with HF at 6 and 12-months post-diagnosis than at the point of diagnosis.

Cardiovascular Medicine